eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 69
Original paper

Effect of sinapic acid on memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats

Pouneh Shahmohamady, Akram Eidi, Pejman Mortazavi, Negar Panahi, Dariush Minai-Tehrani

Pol J Pathol 2018; 69 (3): 266-277
Online publish date: 2018/11/20
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
The present study aimed to elucidate the neuroprotective effect of sinapic acid on intracerebroventricular streptozotocin (ICV-STZ) induced neuronal loss and memory impairment. To test this hypothesis, male Wistar rats were randomly divided into 11 groups: normal control, sham-operated control, sinapic acid (2.5, 5, 10, and 20 mg/kg bw intragastrically, daily) alone, Alzheimer control rats (ICV-STZ, 3 mg/kg bw), sinapic acid (2.5, 5, 10, and 20 mg/kg bw intragastrically, daily) together with STZ, and the treatment was performed accordingly. After 28 days of ICV-STZ administration, the animals were assessed for cognitive performance using passive avoidance test and then sacrificed for biochemical and histopathological examinations. Sinapic acid was found to be effective in improving antioxidant status and preventing memory loss in Alzheimer rats. Moreover, TNF-α level in the hippocampus was significantly decreased by sinapic acid. Also, administration of sinapic acid significantly increased the levels of antioxidant enzymes and decreased malondialdehyde level in the hippocampus. Histopathological examination showed that sinapic acid reduced cell loss in the cerebral cortex and hippocampus in Alzheimer’s rats. The present study suggests that sinapic acid is effective in the prevention of memory loss and improvement of oxidative stress and might be beneficial in the treatment of Alzheimer’s disease.

sinapic acid, streptozotocin, Alzheimer’s disease, rat

Alasalvar C, Karamac M, Amarowicz R, et al. Antioxidant and antiradical activities in extracts of hazelnut kernel (Corylus avellana L.) and hazelnut green leafy cover. J Agric and Food Chem 2006; 54: 4826-4832.
Zou Y, Kim AR, Kim JE, et al. Peroxynitrite scavenging activity of sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) isolated from Brassica juncea. J Agric Food Chem 2002; 50: 5884-5890.
Yun KJ, Koh DJ, Kim SH, et al. Anti-inflammatory effects of sinapic acid through suppression of inducible nitric oxide synthase, cyclooxygenase-2 and proinflammatory cytokines expression via nuclear factor-kB inactivation. J Agric Food Chem 2008; 56: 10265-10272.
Nowak H, Kujawa K, Zadernowski R, et al. Antioxidative and bactericidal properties of phenolic compounds in rapeseeds. Fat Sci Technol 1992; 94: 149-152.
Teixeira J, Gaspar A, Garrido EM, et al. Hydroxycinnamic acid antioxidants: an electrochemical overview. Biomed Res Int 2013; 2013: 251754.
Tesaki S, Tanabe S, Ono H, et al. 4-Hydroxy-3- nitrophenylacetic and sinapic acids as antibacterial compounds from mustard seeds. Biosci Biotechnol Biochem 1998; 62: 998-1000.
Engels C, Schieber A, Ganzle MG. Sinapic acid derivatives in defatted oriental mustard (Brassica juncea L.) seed meal extracts using UHPLC-DAD-ESI-MSn and identification of compounds with antibacterial activity. Eur Food Res Technol 2012; 234: 535-542.
Kanchana G, Shyni WJ, Rajadurai M, et al. Evaluation of antihyperglycemic effect of sinapic acid in normal and streptozotocin-induced diabetes in albino rats. Global J Pharmacol 2011; 5: 33-39.
Barber MS, McConnell VS, DeCaux BS. Antimicrobial intermediates of the general phenylpropanoid and lignin specific pathways. Phytochem 2000; 54: 53-56.
Johnson ML, Dahiya JP, Olkowski AA, et al. The effect of dietary sinapic acid (4-hydroxy-3, 5-dimethoxy-cinnamic acid) on gastrointestinal tract microbial fermentation, nutrient utilization, and egg quality in laying hens. Poul Sci 2008; 87: 958-963.
Yoon BH, Jung JW, Lee JJ, et al. Anxiolyticlike effects of sinapic acid in mice. Life Sci 2007; 81: 234-240.
Roy SJ, Mainzen Prince PS. Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. Eur J Pharmacol 2013; 699: 213-218.
Silambarasan T, Manivannan J, Priya MK, et al. Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats. PLoS One 2014; 9: 115682.
Hudson EA, Dinh PA, Kokubun T, et al. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 2000; 9: 1163-1170.
Kim DH, Yoon BH, Jung WY, et al. Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 2010; 59: 20-30.
Lee HE, Kim DH, Park SJ, et al. Neuroprotective effect of sinapic acid in a mouse model of amyloid β (1–42) protein-induced Alzheimer’s disease. Pharmacol Biochem Behav 2012; 103: 260-266.
Hoyer S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol 2004; 541: 135-152.
Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 2004; 490: 115-125.
Kamat PK, Rai S, Swarnkar S, et al. Mechanism of synapse redox stress in okadaic acid (ICV) induced memory impairment: role of NMDA receptor. Neurochem Int 2014; 76: 32-41.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-56.
Agrawal R, Tyagi E, Shukla R, et al. Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 2011; 21: 261-273.
Labak M, Foniok T, Kirk D, et al. Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer’s disease. Acta Neurochir Suppl 2010; 106: 177-181.
Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 2001; 68: 1021-1029.
Ahmad M, Saleem S, Ahmad AS, et al. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 2005; 93: 94-104.
Ansari MA, Ahmad AS, Ahmad M, et al. Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res 2004; 101: 73-86.
Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney Academic press, 1986.
Sharma M, Gupta YK. Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharmacol 2003; 13: 241-247.
Raghavendra V, Kulkarni SK. Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic Biol Med 2001; 30: 595-602.
Deak T, Bellamy C, D’Agostino LG. Exposure to forced swim stress does not alter central production of IL-1. Brain Res 2003; 972: 53-63.
Elçioğlu HK, Kabasakal L, Tufan F, et al. Effects of systemic Thalidomide and intracerebroventricular etanercept and infliximab administration in a streptozotocin induced dementia model in rats. Acta Histochemica 2015; 117: 176-181.
Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57: 715-724.
Ishrat T, Hoda MN, Khan MB, et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT). Eur Neuropsychopharmacol 2009; 19: 636-647.
Agrawal R, Tyagi E, Shukla R, et al. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 2009; 56: 779-787.
Nitsch R, Hoyer S. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 1991; 128: 199-202.
Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998; 112: 1199-1208.
Salkovic-Petrisic M, Knezovic A, Hoyer S, et al. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J Neural Transm 2013; 120: 233-252.
Hoyer S, Lannert H. Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann N Y Acad Sci 1999; 893: 301-303.
Shoham S, Bejar C, Kovalev E, et al. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 2003; 184: 1043-1052.
Hoyer S, Nitsch R, Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect 1991; 3: 1-14.
Pathan AR, Viswanad B, Sonkusare SK, et al. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci 2006; 79: 2209-2216.
Plaschke K, Hoyer S. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 1993; 11: 477-483.
Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurol 1999; 53: 1937-1942.
Awasthi H, Tota S, Hanif K, et al. Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci 2010; 86: 87-94.
Ishrat T, Khan MB, Hoda MN, et al. Coenzyme Q10 modulates cognitive impairment against intracerebro-ventricular infusion of streptozotocin in rats. Behav Brain Res 2006; 171: 9-16.
Lenard L, Kertes E. Influence of passive avoidance learning by substance P in the basolateral amygdala. Acta Biol Hung 2002; 53: 95-104.
Arendt T. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization. Neurosci 2001; 102: 723-765.
Pratico D, Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer’s disease. Am J Med 2000; 109: 577-585.
Karakida F, Ikeya Y, Tsunakawa M, et al. Cerebral protective and cognition-improving effects of sinapic acid in rodents. Biol Pharm Bull 2007; 30: 514-519.
Sun XL, Ito H, Masuoka T, et al. Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biol Pharm Bull 2007; 30: 1727-1731.
Misra S, Tiwari V, Kuhad A, et al. Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats. Eur J Pharmacol 2011; 659: 177-186.
Kamat PK, Tota S, Rai S, et al. A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats. Life Sci 2012; 90: 713-720.
Wei P, Liu Q, Li D, et al. Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat hippocampus, Neurosci Lett 2015; 604: 161-166.
Qin L, He J, Hanes RN, et al. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 2008; 5: 10.
Frankola KA, Greig NH, Luo W, et al. Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets 2011; 10: 391-403.
Arsenijevic D, Bilbao FD, Giannakopoulos P, et al. A role for interferon-gamma in the hypermetabolic response to murine toxoplasmosis. Eur Cytokine Netw 2001; 12: 518-527.
Victor VM, De la Fuente M. Several functions of immune cells in mice changed by oxidative stress caused by endotoxin, Physiol Res 2003; 52: 789-796.
Fernandez-Botran R, Miller JJ, Burns VE, et al. Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Brain Behav Immun 2011; 25: 314-321.
Gaspar A, Martins M, Silva P, et al. Dietary phenolic acids and derivatives. Evaluation of the antioxidant activity of sinapic acid and its alkyl esters. J Agric Food Chem 2010; 58: 12273-12280.
Ghaznavi R, Kadkhodaee M. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity. Arch Toxicol 2007; 81: 453-457.
Mahmoud AM, Ahmed OM, Galaly SR. Thymoquinone and curcumin attenuate gentamicin-induced renal oxidative stress, inflammation and apoptosis in rats. EXCLI J 2014; 13: 98-110.
Liu R, Liu IY, Bi X, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 2001; 100: 8526-8531.
Wickens AP. Ageing and the free radical theory. Respir Physiol 2001; 128: 379-391.
Williams TI, Lynn BC, Markesbery WR, et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 2006; 27: 1094-1099.
Petursdottir AL, Farr SA, Morley JE, et al. Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM). Neurobiol Aging 2007; 28: 1170-1178.
Nayagam AAJ, Sudhakar N, Manoaran S. Hepatoprotective efficacy of Tricholepis radicans DC against CCl4 induced liver toxicity in albino rats. J Pharm Res 2011; 4: 1073-1075.
Galano A, Francisco-Marquez M, Alvarez-Idaboy JR. Mechanism and kinetics studies on the antioxidant activity of sinapinic acid. Phys Chem Chem Phys 2011; 13: 11199-11205.
Wang X, Pal R, Chen XW, et al. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Brain Res Mol Brain Res 2005; 140: 120-126.
Wilde GJ, Pringle AK, Wright P, et al. Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro. J Neurochem 1997; 69: 883-886.
Roy SJ, Mainzen Prince PS. Protective effects of sinapic acid on lysosomal dysfunction in isoproterenol induced myocardial infarcted rats, Food Chem Toxicol 2012; 50: 3984-3989.
Rai S, Kamat PK, Nath C, et al. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 2013; 254: 1-9.
Pari L, Mohamed Jalaludeen A. Protective role of sinapic acid against arsenic – induced toxicity in rats. Chemi Biol Interact 2011; 194: 40-47.
Silambarasan T, Manivannan J, Priya MK, et al. Sinapic acid protects heart against ischemia/reperfusion injury and H9c2 cardiomyoblast cells against oxidative stress. Biochem Biophys Res Commun 2015; 456: 853-859.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe